Recent Headlines
CrystalGenomics Receives Orphan Drug Designation from the US FDA for CG-745 in Pancreatic Cancer
CrystalGenomics, Inc. (KOSDAQ: 083790) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to CG-745, a clinical stage histone deacetylase (HDAC) inhibitor being developed for several hematologic malignancies and solid tumors, for the treatment of... - August 30, 2019 - CrystalGenomics, Inc.
Zifo RnD Solutions and Scilligence Announce Strategic Partnership
Zifo RnD Solutions and Scilligence Corporation announce a strategic partnership that enables Zifo to provide System Integrations Solutions for Scilligence suite of integrated informatics solutions. The partnership will help clients to easily select, evaluate, and implement solutions that fit their... - August 18, 2019 - Zifo
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
8-year Study Tracks Central Lab Performance and Identifies Covance as Leading the Way in Clinical Investigator Satisfaction. - August 13, 2019 - Life Science Strategy Group, LLC
Global Regenerative Group Becomes Global Partner for Pharmaceutical Wholesaler Prosupplier GmbH Representing Their CureOs® Synthetic BONE GRAFT
Global Regenerative Group, developer and global distributor of new and innovative products in the field of Regenerative Medicine, today announces its partnership with Prosupplier GmbH, a pharmaceutical wholesaler with an experienced and specialist team, whose products include CureOs® Synthetic BONE GRAFT. - August 02, 2019 - Global Regenerative Group
Multiplex ELISAs Offer Powerful Profiling Capabilities
Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. - June 22, 2019 - Cayman Chemical Company
AMT Partners with Medicare for Educational Webinar: Critical Medicare Documentation Requirements for Wound Care Residents
American Medical Technologies has partnered with Durable Medical Equipment Medicare Administrative Contractors (DME MACs), Noridian Healthcare Solutions and CGS Administrators, to host a live educational webinar covering Medicare’s documentation requirements for wound care residents. - June 18, 2019 - American Medical Technologies
The OMEGATOF, a Fully Integrated Benchtop Spectrometer Instrument for High-Mass MALDI Applications with the Power of CovalX Technology Inside
CovalX has partnered with Shimadzu Scientific Instruments to offer the OMEGATOF, an integrated MALDI solution for ultra high-mass detection. With a focus on the detection of large molecules, including biotherapeutics, protein complexes, aggregates, and antibody-antigen interactions in a benchtop... - June 13, 2019 - CovalX
New Research Benchmarks Pharma’s Changing Utilization of Real-World Evidence (RWE) and Its Impact on Contract Research Organizations (CROs)
Study Tracks Utilization of Real-World Data (RWD), Real-World Evidence (RWE) and Supportive Services and Implications to CROs. - June 11, 2019 - Life Science Strategy Group, LLC
Global Regenerative Group (GRG) Announced That the Global Regenerative Academy Has Been Launched
The Global Regenerative Academy is an integral part of the Global Regenerative Group, a privately-held medical technologies company specializing exclusively on Regenerative Medicine and stem cell technologies, products, and therapies that significantly enhance the body’s natural healing ability. - June 06, 2019 - Global Regenerative Group
Matreya, LLC is Now a Part of Cayman Chemical Company to Better Serve the Lipid Community
Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and sterols to be used as research standards. - June 05, 2019 - Cayman Chemical Company
Pillar Clinical Research Announces New Ratings Initiative: Pillar Precision
The Dallas based research company plans to roll out a new clinical rating training program, Pillar Precision. The program includes a clinician guide featuring best practices for specific CNS indications, placebo response training, malingering detection, data-driven decision making, and multi-site... - May 24, 2019 - Pillar Clinical Research
Scientists at AbboMax Developed Antibodies Against PINK1 and Parkin to Study Parkinson’s Disease
A panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson’s disease (PD). These phosphospecific and paired antibodies would be useful tools for studies of PINK/Parkin pathways and signaling in PD. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. AbboMax specializes in high-quality custom service and products focusing on antibody and assay development. - May 09, 2019 - AbboMax, Inc.
Texas Clinical Research Company Announces Expansion and New Quality Assurance Initiative
Pillar Clinical Research (Pillar), with a focus on early and late stage CNS drug development, opens two new US research facilities in Illinois and Arkansas and adds Director of Quality Assurance. Dr. Andrew Kim joined the Chicago team in September of 2018, and has spent over 5 years in clinical... - April 18, 2019 - Pillar Clinical Research
Zifo RnD Solutions Announces Launch of Sci-Desk
Zifo RnD Solutions announced the launch of its latest product Sci-Desk, an on-demand, cloud-based, Scientific Application Support-in-a-box. Sci-Desk offers comprehensive managed services for Scientific & lab computing systems spanning Discovery, R&D and Manufacturing industries. “Sci-Desk is a first of its kind in the Life Science R&D Spectrum. Sci-Desk brings on-demand, scalable, customizable and secure support to scientific applications,” said Raj Prakash, CEO/Co-Founder of Zifo RnD Solutions. - April 18, 2019 - Zifo
YouScript and Genome Medical Announce Partnership to Provide Clinical and Analytics Support for Genetic Risk Management
Connecting precision medicine analytics and genetic services - April 03, 2019 - YouScript
Are Antioxidants the Solution to Burning and Itchy Eyes?
A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University Chicago and the University of Missouri – Kansas City suggests that a topical antioxidant formulation can improve the pathological signs associated with dry-eye disease. - March 26, 2019 - Experimentica Ltd
Huntington Study Group Achieves 100th Credentialed Research Site Milestone
The Huntington Study Group (HSG), a world leader in spearheading research and conducting clinical trials in Huntington disease (HD), is excited to announce that it has credentialed Inland Northwest Research, LLC as the 100th HSG site in North America. “On behalf of myself and our site, I... - March 25, 2019 - Huntington Study Group
Sanyal Biotechnology Hires IQVIA / BuzzeoPDMA DEA Compliance Group
Sanyal Bio has expanded into pre-clinical and clinical contract research on cannabinoids. Sanyal Bio currently holds a DEA Schedule 1 Import License for Cannabis Extracts and THC, with applications pending for Research, Analytical and Manufacturing licenses. IQVIA's DEA Compliance group is well-respected for their expertise and Sanyal Bio looks forward to working with this reputable group going forward. - February 13, 2019 - Sanyal Biotechnology
immunoSCAPE Launches US Office
immunoSCAPE Pte Ltd ("immunoSCAPE" or the "Company"), a leader in immune profiling, today announced the establishment of its first US office in Cambridge, MA. The office will serve as the headquarters of its US based, wholly owned subsidiary immunoSCAPE, Inc. Mr. Choon Peng NG,... - February 11, 2019 - immunoSCAPE Pte Ltd
Global OrthoBiologic Expands Its Operation Under the Name Global REGENERATIVE Group (GRG)
Global OrthoBiologic has announced today that it will expand its operation under the name Global REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida (globalregenerative.group) and will consist of 4 divisions, which will operate independently – Trade, Academy, Care and Finance. - January 16, 2019 - Global Regenerative Group
New Training Workshops Available in Orlando and Nationwide
D.L. Newslow & Associates, Inc. is now offering new quality-focused workshops in addition to a large stable of existing food safety training options. They are also the hosts of the TWI Institute Southeast and Mr. Alan Lane, the author of the Training Within Industry Management System Standard. - January 07, 2019 - D.L. Newslow & Associates, Inc.
CrystalGenomics Signs Export Agreement with PharmArtis for Acelex in Russia
CrystalGenomics, Inc. announced today that they have signed an Export Agreement with PharmArtis International for the commercialization of Acelex® (polmacoxib) in Russia. Based on the terms of the agreement, CrystalGenomics will supply finished product of Acelex to PharmArtis and PharmArtis... - November 24, 2018 - CrystalGenomics, Inc.
VIRUN® and Algarithm™ to Debut O3Omega™ NOT Peanut Butter and Jelly Sandwich Multi-serving Smoothies in Booth 1637 at Supply Side West Expo, Las Vegas on November 8 and 9
Virun® and Algarithm™ offer chill vibe at otherwise chaotic Supplyside West, serve up adult beverages enhanced with DHA and flavored like deserts, to debut new vegan O3Smoothies flavor, NOT Peanut Butter and Jelly. - November 02, 2018 - VIRUN
Creative Enzymes Has Launched New Product Called Pectolyase
Creative Enzymes has announced today that they had just launched a new product called Pectolyase, and declared that they had spent much time on the research and development for the completion of this product because it can greatly accelerate fruit juice filtration and promote clarification in fruit... - October 31, 2018 - Creative Enzymes
2018 (10th) International Conference on Stem Cells Will Commence in Beijing, China
2018 (10th) international conference on stem cells will be held in Beijing on November 9, 2018 and concluded on November 10, 2018. Based on the experience of the previous nine sessions of stem cell clinic and transformation, this conference will focus on stem cell reprogramming and regenerative... - October 28, 2018 - Creative Enzymes
Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
CrystalGenomics Signs Export Agreement with Apsen Farmacêutica for Acelex in Brazil
CrystalGenomics, Inc. announced today that they have signed an Export Agreement with Apsen Farmacêutica for the commercialization of Acelex® (polmacoxib) in Brazil. Under the terms of the agreement, Apsen will secure exclusive rights for the Brazilian market to sell and market Acelex... - September 05, 2018 - CrystalGenomics, Inc.
Trial Runners Strengthens Its Leadership Team
Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners
Cayman Partners with LIPID MAPS® to Support Continued Development of Key Lipidomic Research Resources
Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a curated lipid standards database. - July 21, 2018 - Cayman Chemical Company
New Assay for Immunology Research Quantifies cGAS-Produced 2’3’-cGAMP in Cells
Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive... - July 20, 2018 - Cayman Chemical Company
MoBiTec GmbH Teams Up with ABP Biosciences, US, to Offer Superior Fluorophores at Reasonable Prices
ABP Biosciences invents, develops, and markets innovative products and technologies to scientists engaged in life sciences research, diagnostic R&D, and drug discovery. ABP specializes in the area of fluorescence labeling and detection technologies. - June 06, 2018 - MoBiTec GmbH
Virun® NutraBIOsciences® and Algarithm™ Ingredients Launch O3Omega™ Smoothies in Canada; Patent for Viruns' Spray-Dry Technology Receives Notice of Allowance in U.S.
Virun® NutraBIOsciences® and Algarithm™ Ingredients Announce O3Omega™ Smoothies Line Picked Up by Canadian Retail Giant Co-op so People Can Enjoy Plant-Based Omega 3s Every Day, the Easy Way, Notice of Allowance for Patent Covering Spray-Dried Powders Containing Non-Polar Compounds. - May 10, 2018 - VIRUN
New Purpose-Built MaxSpec™ Standards Available for Quantitative Mass Spectrometry Analysis
Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more... - April 18, 2018 - Cayman Chemical Company
D.L. Newslow & Associates, Inc. Announces Partnership with Savour Food Safety International, Inc.
Two food safety and management systems consulting and training powerhouses are teaming up to take you to the next level. The professional partnership between D.L. Newslow & Associates and Savour Food Safety International brings an exciting and dynamic new angle to the industry, with a fresh face of service to manufacturing companies across the U.S. and beyond. - April 11, 2018 - D.L. Newslow & Associates, Inc.
Growing In Vitro Diagnostics (IVD) Market to Set New Business Opportunities for Start Up Company
Vidan Diagnostics Expected to Provide Access to Unique Tests Related to Monitoring of Diabetes and Sepis. - April 05, 2018 - Vidan Diagnostics, LLC
Proteos, Inc. Honored as One of the 2018 “Best Small Business Honorees”
Proteos, Inc. has been recognized as one of the 2018 “Best Small Businesses,” an awards program presented by Michigan Celebrates Small Business. Proteos will receive the SmartZone Best Small Business of the Year Award and be honored at an awards ceremony during the fourteenth annual... - March 24, 2018 - Proteos
Virun® NutraBIOsciences® Announces Sponsorship of Upcoming Top Shelf Tech Fest 2018, a Music & Technology Festival Celebrating Innovation with Food Technology and Music
Virun® NutraBIOsciences® Showcases Hot Young Musical Talent, Hosts Informative Panel Discussions and Presents its’ New Product Offering to the Masses at Inaugural Music and Food Science Event. - March 01, 2018 - VIRUN
Experimentica Ltd. Amongst the Most Promising Finnish Young Innovative Companies
Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12... - February 21, 2018 - Experimentica Ltd
US Patent Issued on CPSI’s FrostBite™ Pancreas Cancer Cryoablation Catheter
Latest patent covers an endoscopic-based cryocatheter (FrostBite™) designed to provide an advanced approach for targeting pancreatic and other gastroenterological based cancers. - February 15, 2018 - CPSI Biotech
Proteos Moves Toward Employee Ownership
Proteos, Inc. announced on Monday January 29, 2018 that the company would begin the process of restructuring and transitioning to a majority employee-owned corporation. Since its founding in 2003, by Clark W. Smith, Ph.D. and Robert L. Heinrikson, Ph.D., Proteos has been committed to both customer... - February 03, 2018 - Proteos
Improving the Health of South Asians Across the Globe
Many people are looking at their parents, grandparents and families and seeing cancer, diabetes, heart disease and rare diseases, all of which can have a genetic component. South Asians have twice the rate of genetic disease compared to the rest of the world, yet there is far less data, less than 1% of the available data. So people don’t know what they are carrying, and they want better diagnosis and treatments for their family members. #MaptheGap will start to address this. - February 02, 2018 - Map the Gap
Phelix Therapeutics, LLC Awarded Phase I SBIR Grant from NIH to Develop Calpain Therapeutics for Idiopathic Pulmonary Fibrosis
Phelix Therapeutics, LLC is pleased to announce it has received a $201,665 grant from the National Institutes of Health (NIH). This Small Business Innovation Research (SBIR) funding will support Phelix’s continued research of Calpain therapeutics to inhibit myofibroblast generation in... - January 31, 2018 - Phelix Therapeutics, LLC
BioStat Solutions, Inc. (BSSI) Announces New Director of Clinical Operations – Eloi Kpamegan, Ph.D.
BioStat Solutions, Inc. today announced that Eloi Kpamegan, Ph.D. has accepted the position of Director, Clinical Operations. - December 14, 2017 - BioStat Solutions, Inc.
Qualitative Identification of Synthetic Cannabinoids Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-QTOF/MS)
A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent... - December 14, 2017 - Cayman Chemical Company
Creative BioMart to Expand Its Protein Glycosylation Labeling Service Capacity to Meet Rising Demands
Creative BioMart, a global leader in the supply of high quality protein products and efficient protein manufacturing techniques, today announced a major expansion of its Protein Glycosylation Labeling Service capacities as a response to rising customer needs and market demands for characterizing... - November 26, 2017 - Creative Biomart
New Intelligence Tool Helps Researchers Cope with Immuno-Oncology Boom
Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence (www.beacon-intelligence.com), to provide clarity to pharma scientists and strategists in the booming immuno-oncology combination field of study. IO Combination Trials... - November 16, 2017 - Beacon Intelligence
Virun® NutraBIOsciences® Receives Certification for Production of Organic Products While Launching Natural Algal DHA MCT Multi-serving Smoothies
Virun® NutraBIOsciences® Prepares to Enter the Finished Product Market with Novel Flavors and Celebrates State Organic Certification. - November 14, 2017 - VIRUN
Virun® NutraBioSciences®, and Algarithm Ingredients Inc. to Lead Plant-Based Panel at SXSW Conference in 2018
Growing market demand for plant-based DHA omega-3 ingredients intersects with innovative food technology. - November 03, 2017 - VIRUN
Clinerion Expands the Global Coverage of Its Services in the Americas, Adding 60 Million Patients in North America via Partnership with Provisio Inc.
Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc. Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities. - October 30, 2017 - Clinerion
Batavia Biosciences Expands Its Viral Vector and GMP Facilities to Accommodate Increasing Market Demand
Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand. - October 18, 2017 - Batavia Biosciences